In an update on an ongoing intravenous saline bag shortage, US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, said yesterday the situation is improving, and the agency expects that the problems will be resolved well before the next flu season begins.
It includes a profile of what such a vaccine would accomplish and the different research areas needed.
The Centers for Disease Control and Prevention (CDC) today ended its investigation into a multistate outbreak of Salmonella Montevideo linked to raw sprouts.
Japan's health ministry has given fast-track approval to a new flu antiviral with a different mechanism of action than neuraminidase inhibitors that offers a one-dose treatment option, the Wall Street Journal reported today.
The proposed law would direct $200 million a year for 5 years to research.
Adults born from 1958 to 1979 may have experienced a drop in protection against 2009 H1N1 during the 2015-16 flu season because of priming with other H1N1 viruses during their younger years, according to a group led by the US Centers for Disease Control and Prevention.
The findings add more weight to calls for more broadly protective flu vaccines.
About 11% of a population sampled in the Democratic Republic of the Congo (DRC) had Zaire Ebola virus (EBOV) immunoglobulin G antibodies, providing serological evidence of Ebola prevalence in populations not currently experiencing an Ebola outbreak.
The Trump administration is making no effort to prioritize game-changing flu vaccines, the experts say.
The Saudi Arabian Ministry of Health (MOH) recorded two new cases of MERS-CoV in Riyadh in recent days.
On Jan 5, a 48-year-old Saudi man from the country's capital was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus) after presenting with symptoms. He is in stable condition. The MOH said the man had direct contact with camels, a known risk factor for MERS-CoV.